Abstract
Insulinoma is characterized by spontaneous fasting hypoglycemia. Diagnosis relies on inappropriately increased insulin levels (>6 μU/ml), high insulin/glucose ratio (IGR >0.3), raised proinsulin values (>5 pMol/l). A 74-yr-old man was referred to us for episodes of symptomatic hypoglycemia without hyperinsulinemia and imaging [abdominal computed tomography (CT) and magnetic resonance scans] negative for neuroendocrine tumor (NET). During hospitalization severe hypoglycemic crises persisted requiring continuous glucose iv infusion. Insulin values (immunofluorimetric method) were not inappropriately increased, accordingly IGR was normal but C-peptide was in the upper-normal range. Proinsulin levels measured with specific radioimmunoassay were remarkably high. Octreoscan study was negative whereas endoscopic ultrasound disclosed a 10 mm lesion in the body of the pancreas, confirmed by rapid spiral CT scanning with dynamic images. Increased proinsulin levels allowed diagnosis of a secreting NET. After removal of the lesion, the patient experienced hyperglycemia. Histology confirmed a benign NET positively staining for insulin. In conclusion, proinsulin assay is of particular help when immunoreactive insulin, measured by specific new immunometric assays (immunoenzymometric and immunofluorimetric assays), is normal. These methods have good precision and specificity (no cross reactivity with intact or Des 31,32 proinsulin), but rare insulinomas secreting most, or all, of their insulin- like activity as proinsulins would go undetected if insulin levels alone were measured.
Similar content being viewed by others
References
Hirshberg B, Livi A, Bartlett DL, et al. Forty-eight hour fast: The diagnostic test for insulinoma. J Clin Endocrinol Metab 2000, 85: 3222–6.
Hammond PJ, Jackson JA, Bloom SR. Localization of pancreatic endocrine tumours. Clin Endocrinol (Oxf) 1994, 40: 3–14.
Grant CS. Surgical aspects of hyperinsulinemic hypoglycemia. Endocrinol Metab Clin North Am 1999, 28:3, 533–54.
Lawrence JM, Smith T, Iles D, Reckless JPD. Difficult insulinoma. J R Soc Med 2001, 94: 349–50.
Dizon AM, Kowalyk S, Hoogwerf BJ. Neuroglycopenic and other symptoms in patients with insulinomas. Am J Med 1999, 106: 307–10.
Hirshberg B, Skarulis MC, Pucino F, Csako G, Brennan R, Gorden P. Repaglinide-induced factitious hypoglycemia. J Clin Endocrinol Metab 2001, 86: 475–7.
Virally ML, Guillausseau PJ. Hypoglycemia in adults. Diabetes Metab 1999, 25: 477–90.
Dolan JP, Norton JA. Occult insulinoma. Br J Surg 2000, 87: 385–7.
Marks V, Teale JD. Investigation of hypoglycemia. Clin Endocrinol (Oxf) 1996, 44: 133–6.
Young CW, Karam JH. Hypoglycemic disorders. In: Greenspan FS ed. Basic and clinical endocrinology. London: Appleton and Lange. 1991, 651–62.
Chevenne D, Trivin F, Porquet D. Insulin assay and reference values. Diabetes Metab 1999, 25: 459–76.
Service FJ. Diagnostic approach to adults with hypoglycemic disorders. Endocrinol Metab Clin North Am 1999, 28: 3, 519–32.
Kao PC, Taylor RL, Service FJ. Proinsulin by immunochemiluminometric assay for the diagnosis of insulinoma. J Clin Endocronol Metab 1994, 78: 1048–51.
Gorden P, Skarulis MC, Roach P, et al. Plasma proinsulinlike component in insulinoma: a 25-year experience. J Clin Endocrinol Metab 1995, 80: 2844–87.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Piovesan, A., Pia, A., Visconti, G. et al. Proinsulin-secreting neuroendocrine tumor of the pancreas. J Endocrinol Invest 26, 758–761 (2003). https://doi.org/10.1007/BF03347360
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03347360